ABOUT
CANNABICS
PHARMACEUTICALS
CANNABICS
PHARMACEUTICALS
Cannabics Pharmaceuticals has been conducting research on the antitumor effects of cannabinoid formulations on cancer since its establishment in 2012.
- Founded 2012
- Capital Markets: OTCQB (CNBX)
- Capital raised to date: 12M usd
- Licensed by the Israeli Ministry of Health to conduct research using cannabinoids on cancer
- State of the art in-house drug discovery facilities
MANAGEMENT
EYAL BARAD
Co-Founder, Director, CEO
Mr. Barad holds a BA in Economics & International Relations from the Hebrew University in Jerusalem and an MBA with Honors from Haifa University.
Prior to becoming CEO at Cannabics,
Mr. Barad served as Vice President of the Israel Canada Chamber of Commerce, and as CEO of an international digital media company.
GABRIEL YARIV
President, Director, COO
Mr. Yariv holds a BA Cum Laude from Boston University in Philosophy, Political Science and History.
Mr. Yariv brings over 20 years of successful executive experience in the medical industry. Mr. Yariv was part of the funding group of breathID an Oridian medical (now Medtronic) business unit and its subsequent spin off company breath ID Inc. (now Exalenz bio science) which develops and manufactures advanced
non-invasive diagnostic medical devices for gastrointestinal and liver conditions. Mr. Yariv also co-founded Simutec, a medical simulation and training company in Brazil that develops and commercializes advanced personalized virtual reality training programs for physicians,
DR. EYAL BALLAN
Co- Founder, CTO
Holds a Ph.D. In Neurophysiology, Brain Waves and Cortical Connectivity.
After obtaining his Ph.D. He was an entrepreneur in the field of Neurofeedback.
Dr. Ballan holds an MSC from Tel-Aviv University Magna Cum Laude in Molecular Biology and Anticancer Drug Development.
URI BEN-OR
CFO
Has over 20 years of broad experience in corporate finance, accounting, M&A transactions, IPO’s and operations.
Mr. Ben-or is CEO & founder of one of the few financial firms in Israel to have the international standard on assurance engagement (ISAE 3402/SAS 70 type ii) assurance with control compliances, the new global standard for assurance reporting. He previously served as an auditor at Price Waterhouse Coopers (PWC) accounting firm.
Mr. Ben-Or holds a BA in Business from the College of Administration and an MBA from the Bar-Ilan University and is a Certified Public Accountant (CPA).
DR. ILAN HOCHMAN
VP of R&D
Dr. Hochman holds a PhD in cancer Immunology.
He brings more than 20 years of experience in versatile R&D leadership and management positions in Innovative biotechnology and startup companies. Before joining Cannabics, Dr. Hochman was a co-founder and VP of R&D at SURI Technologies, a company focusing on developing personalized cancer immunotherapy. Previously he was the founder of Biology Research Services, a company that provided Tailor-made solutions for startups research, and managed the bioassay and HTS units at QBI and Rosetta Genomics.
DR. LIOR ESHDAT
IP Manager
Dr. Eshdat holds a Ph.D. in organic chemistry and brings over 13 years of experience in intellectual property practice.
Before he became an Israeli Patent Attorney he held a post-doctoral research fellowship at the University of Boulder and was a senior chemist in Dynamic Organic Light which developed OLED display technologies in Colorado.
Dr. Eshdat gained his IP experience as a patent attorney associate in Reinhold Cohn, a leading Israeli IP Firm, in the in-house IP departments in Adama, a global agchem corporate, and through his own practice providing IP consultancy and patent attorney services to inventors, start-ups, entrepreneurs and hedge funds.
Dr. Eshdat gained his IP experience as a patent attorney associate in Reinhold Cohn, a leading Israeli IP Firm, in the in-house IP departments in Adama, a global agchem corporate, and through his own practice providing IP consultancy and patent attorney services to inventors, start-ups, entrepreneurs and hedge funds.
DAVID E. PRICE
ESQ
Took the company public on the US capital market and is a native
Washingtonian.
David brings a dynamic and varied background, having worked in the Diplomatic Corps in the Israeli Foreign Office as well as a Congressional Aide in the US congress, and General Counsel to consultants at the World Bank as well as the IDB, ex-im and IMF in Washington, DC.
ADVISORY BOARD
DR. GIL FEILER
Head Of Advisory Board
Former board member of Advanced Vision Technology (FTX: VSJ), board
of Safra bank mutual fund division,
administrative advisor for the
government of Ras Al Khaimah, UAE.
Author of numerous publications, a known speaker at leading business events including Davos world economic forum.
Author of numerous publications, a known speaker at leading business events including Davos world economic forum.
PROF. ZAMIR HALPERN
Medical Advisor
Prof. Halpern, Senior Physician at the Gastroenterology institute in the Sourasky Medical Center in Tel-Aviv, Israel, served as Chairman of the Israeli Association of the Study of Liver, Chairman of the Israeli Gastroenterology Association, Chairman of the National Council for Food and Agriculture and is now Chairman of the National Gastro Nutrition and Liver Diseases Council at the Ministry of Health.
DR. EREZ SCAPA
Medical Advisor
Dr. Scapa earned his M.D in 2000 at the Technion Institute of Technology in Haifa, Israel, cum laude. He later held a Research Fellowship in Hepatology at the Brigham and Women’s Hospital, Harvard University, Boston, MA, as well as a fellowship in Endoscopic
Submucosal Dissection at the NTT Medical Center in Tokyo, Japan. He is an expert in invasive Endoscopy and has extensive experience in
performing colonoscopies and
gastroscopies. He is proficient in both diagnostic as well as invasive
Endoscopic US (EUS) and serves as the head of the Endoscopic
Submucosal Dissection (ESD) program in Tel-Aviv Sourasky Medical Center, initiated in 2019.
PROF. AMOS TOREN, MD
Medical Advisor
Prof. Amos Toren is the Director of
Pediatric Hemato- Oncology and BMT department at the Sheba Medical Center since 2001 and a Professor in the division of Hematology,Sackler school of medicine tel-aviv university.
Prof. Toren is a specialist in Pediatrics, General Hematology and Pediatric Hemato-oncology. He also has a Ph.D degree in genetics and qualified as a master of health administration (MHA) at the Recannati Business School, Tel-Aviv University.
Prof. Toren is a specialist in Pediatrics, General Hematology and Pediatric Hemato-oncology. He also has a Ph.D degree in genetics and qualified as a master of health administration (MHA) at the Recannati Business School, Tel-Aviv University.
DR. TAL MOFKADI
Financial Advisor
Dr. Mofkadi holds a Ph.D in Financial Economics from Tel Aviv University. He is a lecturer at Tel Aviv University, the Interdisciplinary Center in Herzliya and universities abroad.
He is the author of ‘The Handbook of Corporate Valuation’.
Dr. Mofkadi provides expert opinions in financing, economic, and legal proceedings, writing valuations and optimal pricing policies as well as economic analysis of competition and regulatory aspects, risk assessment and more.
He is the author of ‘The Handbook of Corporate Valuation’.
Dr. Mofkadi provides expert opinions in financing, economic, and legal proceedings, writing valuations and optimal pricing policies as well as economic analysis of competition and regulatory aspects, risk assessment and more.
DR. SIGALIT ARIELY PORTNOY
Regulatory Advisor
Dr. Sigalit Ariely-Portnoy has vast
experience in the pharmaceutical
industry and managed pharmaceutical and chemical plants at Taro
Pharmaceutical Industries LTD as
Operation Group Vice President and in Teva Pharmaceutical industries LTD as OSD plant manager.
In the last 7 years, Sigalit is the CEO of GSAP, the largest consulting company for pharmaceutical and medical device companies in Israel.
Sigalit Ariely-Portnoy has a BSC and Ph.D in Chemical Engineering and MSC in Bio-Medical engineering from the Technion – Israel Institute of Technology, Haifa, Israel. regulatory aspects, risk assessment and more.
In the last 7 years, Sigalit is the CEO of GSAP, the largest consulting company for pharmaceutical and medical device companies in Israel.
Sigalit Ariely-Portnoy has a BSC and Ph.D in Chemical Engineering and MSC in Bio-Medical engineering from the Technion – Israel Institute of Technology, Haifa, Israel. regulatory aspects, risk assessment and more.
DR. DANA BEN-AMI SHOR
Medical Advisor
Dr. Ben-Ami Shor is a recognized expert in invasive endoscopy and gastroenterology in the Sourasky Medical Center in Tel-Aviv, Israel.
Dr. Ben-Ami Shor earned her M.D in 2009, graduating cum laude from the Sackler Faculty of Medicine, Tel Aviv University. She specialized in internal medicine and gastroenterology at the Sheba Medical Center, Israel. She also successfully completed an advanced endoscopy (ASGE) accredited fellowship within the Center for Interventional Endoscopy at AdventHealth, in Florida.
Additionally, Dr. Ben-Ami Shor is proficient in both diagnostic and therapeutic endoscopic ultrasound (EUS), and endoscopic retrograde cholangiopancreatography (ERCP).
Dr. Ben-Ami Shor earned her M.D in 2009, graduating cum laude from the Sackler Faculty of Medicine, Tel Aviv University. She specialized in internal medicine and gastroenterology at the Sheba Medical Center, Israel. She also successfully completed an advanced endoscopy (ASGE) accredited fellowship within the Center for Interventional Endoscopy at AdventHealth, in Florida.
Additionally, Dr. Ben-Ami Shor is proficient in both diagnostic and therapeutic endoscopic ultrasound (EUS), and endoscopic retrograde cholangiopancreatography (ERCP).